Amgen (AMGN) Net Cash Flow (2009 - 2026)

Amgen's Net Cash Flow history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• In Q1 2026, Net Cash Flow rose 191.97% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 459.47% YoY), while the FY2025 annual figure was -$2.8 billion, down 376.38% from the prior year.
• Net Cash Flow was $2.9 billion for Q1 2026 at Amgen, up from -$316.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $23.9 billion in Q1 2023 to a low of -$23.8 billion in Q4 2023.
• Historically, Net Cash Flow has averaged $238.2 million across 5 years, with a median of -$316.0 million in 2025.
• Biggest YoY gain for Net Cash Flow was 1737.99% in 2023; the steepest drop was 1170.53% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$1.9 billion in 2022, then tumbled by 1170.53% to -$23.8 billion in 2023, then surged by 112.45% to $3.0 billion in 2024, then tumbled by 110.67% to -$316.0 million in 2025, then surged by 1020.57% to $2.9 billion in 2026.
• The last three Net Cash Flow figures came in at $2.9 billion (Q1 2026), -$316.0 million (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.